biostudies-literatureMsoka EFEuropean & Developing Countries Clinical Trials Partnership (EDCTP)FIC NIH HHSe050911https://www.ebi.ac.uk/biostudies/studies/S-EPMC8276309biostudies-literatureUnknown11(7)<h4>Objectives</h4>Early diagnosis and timely treatment are key elements of a successful healthcare system. We assessed the role of socioeconomic and cultural norms in accelerating or decelerating uptake and utilisation of health technologies into policy and practice.<h4>Setting</h4>Secondary and tertiary level healthcare facilities (HCFs) in three East African countries. Level of HCF was selected based on the WHO recommendation for implantation of tuberculosis (TB) molecular diagnostics.<h4>Participants</h4>Using implementation of TB diagnostics as a model, we purposively selected participants (TB patients, carers, survivors, healthcare practitioners, community members, opinion leaders and policy-makers) based on their role as stakeholders. In-depth interviews, key informant interviews anBMJ openQualitative assessment of the impact of socioeconomic and cultural barriers on uptake and utilisation of tuberculosis diagnostic and treatment tools in East Africa: a cross-sectional study.PMC8276309TWENDE-EDCTP-CSA-2014-283D43 TW010319Msoka EFMwebaza ISabiiti WOrina FMiheso BKiula KJoloba MNtinginya NEAturinde AMwanyonga SMmbaga BAmukoye ELiyoyo AGillespie SHSanga ESMeme HfalseQualitative assessment of the impact of socioeconomic and cultural barriers on uptake and utilisation of tuberculosis diagnostic and treatment tools in East Africa: a cross-sectional study.<h4>Objectives</h4>Early diagnosis and timely treatment are key elements of a successful healthcare system. We assessed the role of socioeconomic and cultural norms in accelerating or decelerating uptake and utilisation of health technologies into policy and practice.<h4>Setting</h4>Secondary and tertiary level healthcare facilities (HCFs) in three East African countries. Level of HCF was selected based on the WHO recommendation for implantation of tuberculosis (TB) molecular diagnostics.<h4>Participants</h4>Using implementation of TB diagnostics as a model, we purposively selected participants (TB patients, carers, survivors, healthcare practitioners, community members, opinion leaders and policy-makers) based on their role as stakeholders. In-depth interviews, key informant interviews an2021-01-01T00:00:00Z2021 Jul2026-05-08T04:16:29.782Z2022-02-11T05:38:57.676ZS-EPMC82763093425367710.1136/bmjopen-2021-050911